-

Komodo Health Appoints Mark Jewett to Chief Marketing Officer

Veteran marketing executive from Microsoft, Tableau, and Informatica to lead marketing and scale Komodo's AI-first strategy

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced the appointment of Mark Jewett as Chief Marketing Officer (CMO). Jewett will lead the company’s marketing, shaping brand, communications, and go-to-market strategy as it scales Marmot™ — its new AI platform designed to help Life Sciences and healthcare organizations innovate faster and serve patients better.

The appointment comes following a period of significant momentum for Komodo Health, including the recent launch of Marmot and recognition on the 2025 Forbes Cloud 100 and TIME's World's Top HealthTech Companies. As demand for AI-powered healthcare intelligence accelerates across the Life Sciences industry, Komodo is scaling to meet growing customer demand, requiring stronger marketing leadership to expand market awareness and drive platform deployment.

Jewett brings more than 25 years of experience leading marketing teams at major technology companies including Microsoft, Tableau, and Informatica. Throughout his career, he has focused on marketing data and AI solutions — from SQL Server and Azure at Microsoft to data analytics at Tableau and AI-powered data management at Informatica. He has a proven track record of leveraging technology and storytelling to drive growth at scale.

“Mark brings proven marketing leadership to meet the strong demand we’ve received for Marmot, our AI-powered healthcare intelligence platform designed to accelerate healthcare innovation and improve patient outcomes," said Web Sun, President and Co-Founder of Komodo Health. "His expertise in scaling marketing organizations and translating complex technology into compelling narratives positions him to amplify Komodo's market leadership as we advance our AI-first vision."

As CMO, Jewett will oversee all marketing functions, including brand strategy, product marketing, communications, demand generation, and go-to-market execution. He will be responsible for strengthening Komodo's market leadership and driving awareness of how Marmot is transforming the speed and rigor of critical healthcare decision-making.

"I'm excited to join Komodo at such a transformative moment," Jewett said. "Komodo is uniquely positioned to help apply AI to reduce the burden of disease. I've seen firsthand how the right combination of technology and storytelling can accelerate market adoption."

About Komodo Health

Komodo Health is on a mission to reduce the global burden of disease by building foundational AI for how Life Sciences and healthcare organizations discover, develop, and deliver life-saving therapies. The company's healthcare-native AI platform Marmot, powered by its Healthcare Map®, eliminates slow, fragmented analyses to accelerate critical healthcare decisions across the product life cycle — from trial design to launch strategy to post-market evidence generation. For more information, visit www.komodohealth.com.

Contacts

Media Contacts
Rowena Kelley
858.405.1971
media@komodohealth.com

Real Chemistry for Komodo Health
KomodoHealthTeam@realchemistry.com

Komodo Health


Release Versions

Contacts

Media Contacts
Rowena Kelley
858.405.1971
media@komodohealth.com

Real Chemistry for Komodo Health
KomodoHealthTeam@realchemistry.com

Social Media Profiles
More News From Komodo Health

Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health®, the leader in AI-powered healthcare intelligence, today announced an expanded strategic partnership with Alnylam Pharmaceuticals (Nasdaq: ALNY), the leading RNAi therapeutics company to scale Marmot™, Komodo’s analytics AI platform, across key enterprise functions at Alnylam. Built on the Healthcare Map®, the industry’s most comprehensive view of more than 330 million de-identified patient journeys, Marmot helps organizations move beyon...

Komodo Health Evolves Leadership Structure and Names Miles Ennis President

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health®, the leader in AI-powered healthcare intelligence, today announced an evolution of its executive leadership structure to accelerate the company’s next phase of growth and reinforce its position as the leading vertical AI company in healthcare and Life Sciences.As part of this evolution, Miles Ennis has been appointed President, and co-Founder Web Sun will assume the role of co-Chief Executive Officer alongside co-Founder and CEO Arif Nath...

Komodo Health Appoints Paul Thomas as Chief Financial Officer

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced the promotion of Paul Thomas to Chief Financial Officer (CFO). In this role, Thomas, who has served as Senior Vice President of Finance and Acting CFO since April 2025, will oversee Komodo’s finance organization and enterprise financial strategy. The appointment comes as the industry reaches an inflection point, with organizations moving beyond using AI as a productivity l...
Back to Newsroom